Life Sciences In Action Podcast: Interview with Brad Brown, CEO of ATL Technologies on Tariffs, Manufacturing Overseas, Quality and More
January 17, 2019
The recent tariffs placed on imports have complicated the manufacturing and distribution processes for any life sciences company doing business overseas. In the pilot episode of the Life Scienes in Action Podcast Series, BioUtah president and CEO, Kelvyn Cullimore, interviews Brad Brown, CEO and chairman of ATL Technology, to discuss how the tarriffs have impacted their business. Other topics discussed include:
- Factors influencing overseas manufacturing
- The importance of quality in the manufacturing process
- Vertical integration of the manufacturing process
- What to look for when selecting a medical device manufacturer
- The importance of life sciences companies participating in BioUtah
Recent News
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
- KyphoLift Debuts at ISMRM 2025: Transforming Patient Positioning for Safer, More Accurate Imaging
- Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
- Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
- Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
- Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
